About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 114 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 114 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 114 trials

Not yet recruitingEvaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple SclerosisThis clinical research study is investigating whether the EXOPULSE Suit, a wearable device that delivers electrical stimulation, can help improve movement difficulties caused by…NCT07897760·Chicago, Illinois and 1 other UnknownLongitudinal Optic Neuritis Study (LONS)To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis. To determine the natural history of vision in patients who suffer optic neuritis.NCT00000147·Little Rock, Arkansas and 14 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingA Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the…NCT06433752·Birmingham, Alabama and 112 others

CompletedA Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During PregnancyThis study will evaluate the potential placental transfer of ocrelizumab in pregnant women with clinically isolated syndrome (CIS) or multiple sclerosis (MS) \[in line with the…NCT04998812·San Francisco, California and 10 others

RecruitingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOThis phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum…NCT03816345·Birmingham, Alabama and 51 others

CompletedMechanism of Action of Ocrelizumab in Multiple SclerosisOcrelizumab is FDA approved for therapy of multiple sclerosis (MS). It depletes B cells and stops MS inflammation.NCT03344094·Chicago, Illinois

Active not recruitingA Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisThis is a Phase IIIb, single-arm, multicenter, OLE study.NCT05269004·Phoenix, Arizona and 231 others

UnknownPhysiology of Interregional Connectivity in the Human BrainThe purpose of this study is to understand the physiology of connectivity between cortical regions in the human brain in healthy participants and in patients with white matter…NCT03723434·Chicago, Illinois

CompletedA Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving OcrelizumabThis study will evaluate the pharmacokinetics of ocrelizumab in the breastmilk of lactating women with clinically isolated syndrome (CIS) or multiple sclerosis (MS) \[in line with…NCT04998851·San Francisco, California and 7 others

Active not recruitingLifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple SclerosisThe overall objective of the current study is to determine the efficacy of a 16-week remotely delivered lifestyle behavioral intervention compared with a control condition (i.e.…NCT06355804·Chicago, Illinois

RecruitingRE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesThe purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in…NCT07002034·Birmingham, Alabama and 32 others

CompletedA Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple SclerosisThis randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in…NCT01247324·Phoenix, Arizona and 141 others

CompletedBEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) PatientsThe purpose of this study is to determine * whether treatment with Betaferon / Betaseron (interferon beta-1b) 500 micrograms safe, tolerable and more efficacious than treatment…NCT00099502·Birmingham, Alabama and 198 others

CompletedLong-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)The objective of this study was to collect data both retrospectively and prospectively in order to evaluate the long-term outcomes, durability of effect, and real-world treatment…NCT03961204·Atlanta, Georgia and 98 others

CompletedPilot Test of ACTOS in Multiple Sclerosis: Safety and TolerabilityThe purpose of this study is to determine whether an already FDA approved drug is safe and tolerable in Relapsing Remitting Multiple Sclerosis patients.NCT00242177·Chicago, Illinois

CompletedStem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized StudyMultiple sclerosis (MS) is at onset an immune-mediated demyelinating disease.NCT00273364·Chicago, Illinois

CompletedSafety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple SclerosisThe objectives of the study are to evaluate the safety, tolerability, and efficacy of 3 doses of AVP-923 capsules in the treatment of central neuropathic pain in participants with…NCT01324232·Cullman, Alabama and 71 others

CompletedExploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)Evaluate the safety and efficacy of Siponimod (BAF312) versus placebo in a variable treatment duration in patients with secondary progressive multiple sclerosis (Core Part)…NCT01665144·Phoenix, Arizona and 289 others

RecruitingOcrevus Zunovo for MS: Mixed MethodsOcrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods…NCT07710105·Chicago, Illinois

CompletedLong-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple SclerosisThis study consisted of a two year dose blinded phase during which patients received one of five doses of siponimod (10, 2, 1.25, 0.5 or 0.25mg) following which patients were…NCT01185821·Miami, Florida and 45 others

PreviousPage 4 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia